REGENERATIVE PHENOMENA IN THE DEVELOPING ORGAN OF CORTI
Project Number1R01DC000844-01A1
Contact PI/Project LeaderSOBKOWICZ, HANNA M
Awardee OrganizationUNIVERSITY OF WISCONSIN-MADISON
Description
Abstract Text
The long-term goal of the proposed research is to gain understanding of
the process of regeneration of sensory and nerve cells following
mechanical injury to the cochlea in culture, and to define the factors
that lead to their morphological recovery. In light of the lack of overt
evidence proving that the mammalian organ of Corti is able to form new
sensory cells, and given the fact that these cells are few and may be
formed only once in a life span the significance of the research lies in
understanding the mechanism of survival and recovery of receptor cells
after injury.
Specifically, we propose to study: 1) Post-traumatic cell proliferation
in the organ of Corti: A) Mitotic cell proliferation in the injured
cultures will be examined using 3H thymidine to investigate the identity
of dividing cells, the duration of the mitotic response and the age-
related occurrence of cell division; B) Nonmitotic cell proliferation,
expressed by extensive sprouting of supporting cells, will be
investigated in search of possible diffusable growth factors (NGF, EGF,
FGF) released by the cells in response to direct injury or to the injury
of sensory cells. 2) Regeneration of the injured sensory cells,
especially the reformation of their cuticular plates and stereocilia.
The study will encompass the morphological sequence of the regenerative
phenomena, its comparison with normal development, and the influence of
age on the regenerative capacity of sensory cells. 3) Degeneration and
regeneration of spiral neurons, sprouting of their endings (using
antibodies to GAP-43 and NF proteins), and formation of new ribbon
synapses.
The study will be done using short- and long-term cultures of the mouse
organ of Corti. The injury will be done by hand, using either a pulled-
glass pipettes or a laser. Light and electron microscopy,
autoradiography, biochemistry and immunocytochemistry will be employed.
Some specialized immunological assays will be done in collaboration with
Dr. Philippe Lefebvre, University de Liege, Belgium.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
developmental neurobiologyear hair cellelectron microscopyepidermal growth factorfibroblast growth factorimmunocytochemistryinjurylaboratory mousenervous system regenerationneural degenerationneurotrophic factorsnewborn animalsorgan of Cortisynaptogenesistissue /cell culture
National Institute on Deafness and Other Communication Disorders
CFDA Code
DUNS Number
161202122
UEI
LCLSJAGTNZQ7
Project Start Date
01-July-1992
Project End Date
30-June-1996
Budget Start Date
01-July-1992
Budget End Date
30-June-1993
Project Funding Information for 1992
Total Funding
$142,108
Direct Costs
$98,686
Indirect Costs
$43,422
Year
Funding IC
FY Total Cost by IC
1992
National Institute on Deafness and Other Communication Disorders
$142,108
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01DC000844-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01DC000844-01A1
Patents
No Patents information available for 1R01DC000844-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01DC000844-01A1
Clinical Studies
No Clinical Studies information available for 1R01DC000844-01A1
News and More
Related News Releases
No news release information available for 1R01DC000844-01A1
History
No Historical information available for 1R01DC000844-01A1
Similar Projects
No Similar Projects information available for 1R01DC000844-01A1